Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
All content for Fast Five Medtech News Podcast is the property of MassDevice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
Medtronic exits ventilator market; BioSig will 'substantially' cut operations
Fast Five Medtech News Podcast
12 minutes 28 seconds
1 year ago
Medtronic exits ventilator market; BioSig will 'substantially' cut operations
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 21, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Better Therapeutics won an FDA breakthrough designation for its liver disease-treating digital therapeutic system. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the therapeutic and how it earned the breakthrough nod.
EnsoData won an FDA nod for its AI sleep diagnosis technology that uses pulse oximeters. Hear what sets this technology apart from other sleep apnea tracking technology.
The FDA has cleared a wearable EP monitoring patch from X-trodes. Whooley explains how the technology works and what executives are saying about the future of the device.
BioSig reduced its workforce for a second time in less than a month as it looks to 'substantially' cut operations. The Fast Five hosts talk about the reason behind the layoffs.
Medtronic is exiting the ventilator market. Learn what the company plans to do with its existing respiratory business and how imperative ventilators were to Medtronic.
BONUS: Read Danielle Kirsh's latest analysis of the medtech stock market in 2023 – How GLP-1s tanked and reshaped the medtech stock market in 2023: Analysts weigh in on how the GLP-1 craze caused one of the biggest swings in the medtech stock market in recent years.
Fast Five Medtech News Podcast
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
